By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences said in a filing with the US Securities and Exchange Commission Friday that it has approximately $200,000 in cash and cash equivalents remaining and will require "significant additional capital" to continue operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.